An appraisal of practice guidelines for smoking cessation in people with severe mental illness
- 31 August 2017
- journal article
- research article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 51 (11) , 1106-1120
Abstract
Objective: To review the quality of current smoking cessation guidelines that include recommendations for people with severe mental illness. Methods: A systematic search of scientific databases, central government health authority websites, psychiatry peak bodies, guideline clearing houses and Google was undertaken for relevant smoking cessation guidelines. Three reviewers independently assessed guideline quality using the AGREE II (Appraisal of Guidelines for REsearch and Evaluation II) instrument. Two reviewers extracted recommendations specific to smokers with severe mental illness. Results: Thirteen guidelines met the inclusion criteria. Seven guidelines scored ⩾60% in at least four domains. Median scores for ‘Editorial independence’, ‘Rigour of development’, ‘Stakeholder Involvement’ and ‘Applicability’ were less than 60%. The highest median scores were for ‘Scope and purpose’ (87%, 69–96%) and ‘Clarity of presentation’ (87%, 56–98%). ‘Editorial independence’ (33.3%, 0–86%) and ‘Rigour of development’ (54%, 11–92%) had the lowest median domain scores. The guidelines varied greatly in their recommendations but the majority recommended nicotine replacement therapy, bupropion or varenicline as first-line pharmacotherapy, along with behavioural support. Conclusion: Many guidelines did not adequately report their methods or the competing interests of the authors. Future guidelines development may benefit from more specifically addressing AGREE II criteria and the needs of smokers with severe mental illness.Keywords
This publication has 31 references indexed in Scilit:
- High Methodologic Quality But Poor Applicability: Assessment of the AAOS Guidelines Using The AGREE II InstrumentClinical Orthopaedics and Related Research, 2014
- The Renormalization of Smoking? E-Cigarettes and the Tobacco “Endgame”New England Journal of Medicine, 2014
- The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registersBMJ, 2013
- Stakeholder Involvement: How to Do It Right: Article 9 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop ReportProceedings of the American Thoracic Society, 2012
- Appraisal of WHO Guidelines in Maternal Health Using the AGREE II Assessment ToolPLOS ONE, 2012
- Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional studyBMJ, 2011
- AGREE II: advancing guideline development, reporting and evaluation in health careCanadian Medical Association Journal, 2010
- Smoking and mental illness: results from population surveys in Australia and the United StatesBMC Public Health, 2009
- Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-reviewBMC Medical Informatics and Decision Making, 2008
- The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta‐analysis*Addiction, 2007